跳至主要内容
临床试验/NL-OMON26849
NL-OMON26849已完成不适用

Prospective Analysis of an individualized dosing Regimen of ATG (Thymoglobulin) in Children Undergoing HCT: redUcing Toxicity and improving Efficacy – a single arm phase II study

MC Utrecht0 个研究点目标入组 53 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
53

研究概览

简要总结

Admiraal et al, Clinical Pharmacokinetics 2014
Admiraal et al, Lancet Haematology 2015.

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients eligible for a non-haplo-identical non-T-cell depleted HCT with Thymoglobulin as part of the conditioning regimen treated in the pediatric ward of the participating centers
  • - Any hematopoietic stem cell source

排除标准

  • - Ex-vivo T-cell depleted grafts
  • - Other serotherapy in conditioning (e.g. Campath, or Campath in the bag)

研究者

发起方
MC Utrecht

相似试验